Earnings Per Share, Basic in USD/shares of Protara Therapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Protara Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2021 to Q3 2025.
  • Protara Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.31 USD/shares, a 38% increase year-over-year.
  • Protara Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -1 USD/shares, a 57.4% increase year-over-year.
  • Protara Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -2.17 USD/shares, a 39.2% increase from 2023.
  • Protara Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -3.57 USD/shares, a 39.1% increase from 2022.
  • Protara Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -5.86 USD/shares, a 39.2% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Protara Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 $0 +$0.19 +38% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$1 $0 +$0.10 +22.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 -$1 $0 +$0.68 +70.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$2 $0 +$0.65 +72.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-05
Q3 2024 -$2 -$1 +$0.37 +42.5% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$3 $0 +$0.55 +55% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 -$3 -$1 $0 -21.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$3 -$1 +$2.56 +74% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-05
Q3 2023 -$6 -$1 $0 -27.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$5 -$1 $0 -31.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$5 -$1 +$0.16 +16.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$5 -$3 -$3 -280% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$3 -$1 +$0.28 +29.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$3 -$1 +$0.38 +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$3 -$1 +$0.24 +20% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$4 -$1 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05

Protara Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 +$1.40 +39.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 -$4 +$2.29 +39.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 -$6 -$2 -39.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$4 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.